Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGR.L Regulatory News (MGR)

  • There is currently no data for MGR

Form 8.3 - Brit plc

26 Feb 2015 11:57

Miton Group Plc - Form 8.3 - Brit plc

Miton Group Plc - Form 8.3 - Brit plc

PR Newswire

London, February 26

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Identity of the person whose positions/ CF MITON UK MULTI CAP INCOMEdealings are being disclosed: FUND THE DIVERSE INCOME TRUST PLC THE INVESTMENT COMPANY PLC MITON INCOME FUND (b) Owner or controller of interests and short MITON GROUP PLCpositions disclosed, if different from 1(a): The naming of nominee or vehicle companies isinsufficient (c) Name of offeror/offeree in relation to BRIT PLCwhose relevant securities this form relates: Use a separate form for each offeror/offeree (d) If an exempt fund manager connected withan offeror/offeree, state this and specifyidentity of offeror/offeree: (e) Date position held/dealing undertaken: 25 FEBRUARY 2015 (f) Has the discloser previously disclosed, or NOare they today disclosing, under the Code inrespect of any other party to this offer? 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE 1. Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: ORDINARY SHARES Interests Short positions Number % Number % (1) Relevant securities owned 3,786,532 0.94%and/or controlled: (2) Derivatives (other thanoptions): (3) Options and agreements topurchase/sell: TOTAL: 3,786,532 0.94% All interests and all short positions should be disclosed. Details of any open derivative or option positions, or agreements to purchaseor sell relevant securities, should be given on a Supplemental Form 8 (OpenPositions). (b) Rights to subscribe for new securities (including directors' and otherexecutive options) Class of relevant security inrelation to which subscription rightexists: Details, including nature of therights concerned and relevantpercentages: If there are positions or rights to subscribe to disclose in more than oneclass of relevant securities of the offeror or offeree named in 1(c), copytable 2(a) or (b) (as appropriate) for each additional class of relevantsecurity. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (a) Purchases and sales Class of relevant Purchase/sale Number of Price per unit security securities Ordinary Shares Sale 240,178 £3.03725 (b) Derivatives transactions (other than options) Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry Optionrelevant description purchasing, securities price date moneysecurity e.g. call selling, to which per unit e.g. paid/ option varying option American, received etc. relates European per unit etc. (ii) Exercising Class of relevant Product Number of Exercise price per security description securities unit e.g. call option (d) Other dealings (including subscribing for new securities) Class of relevant Nature of dealing Details Price per unit security (if applicable) e.g. subscription, conversion The currency of all prices and other monetary amounts should be stated. Where there have been dealings in more than one class of relevant securities ofthe offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (asappropriate) for each additional class of relevant security dealt in. 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement orunderstanding, formal or informal, relating to relevant securities which maybe an inducement to deal or refrain from dealing entered into by the personmaking the disclosure and any party to the offer or any person acting inconcert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none" NONE (b) Agreements, arrangements or understandings relating to options orderivatives Details of any agreement, arrangement or understanding, formal or informal,between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevantsecurities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 26 FEBRUARY 2015 Contact name: PHILIP OST Telephone number: 02037141477 Public disclosures under Rule 8 of the Code must be made to a RegulatoryInformation Service and must also be emailed to the Takeover Panel atmonitoring@disclosure.org.uk . The Panel's Market Surveillance Unit isavailable for consultation in relation to the Code's dealing disclosurerequirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Date   Source Headline
10th Nov 201711:01 amRNSHolding(s) in Company
6th Nov 20175:18 pmRNSHolding(s) in Company
1st Nov 201712:20 pmPRNForm 8.3 - Clinigen Group Plc
31st Oct 20178:06 amRNSDirector dealings
26th Oct 20174:53 pmRNSHolding(s) in Company
25th Oct 201711:23 amRNSDirector dealings
23rd Oct 201710:24 amPRNForm 8.3 - Belvoir Lettings Plc
23rd Oct 201710:12 amPRNForm 8.3 - Property Franchise Group PLC
19th Oct 20174:43 pmRNSHolding(s) in Company
19th Oct 20172:53 pmRNSHolding(s) in Company
19th Oct 20171:54 pmRNSHolding(s) in Company
18th Oct 20179:37 amRNSExchange of shares under the Growth Share Plan
16th Oct 20175:29 pmRNSHolding(s) in Company
12th Oct 201710:40 amRNSHolding(s) in Company
9th Oct 20171:20 pmRNSHolding(s) in Company
27th Sep 20172:54 pmRNSHolding(s) in Company
25th Sep 20173:37 pmRNSHolding(s) in Company
22nd Sep 201712:05 pmRNSHolding(s) in Company
21st Sep 20173:31 pmRNSDirector dealings
21st Sep 20179:33 amRNSHolding(s) in Company
21st Sep 20177:01 amRNSHalf-year Report
21st Sep 20177:00 amRNSDirectorate Change
20th Sep 201710:15 amRNSHolding(s) in Company
15th Sep 20172:00 pmRNSHolding(s) in Company
15th Sep 20179:39 amRNSHolding(s) in Company
14th Sep 20174:10 pmRNSHolding(s) in Company
11th Sep 20179:56 amPRNForm 8.3 - Novae Group Plc
8th Sep 20175:00 pmRNSHolding(s) in Company
7th Sep 20172:21 pmRNSHolding(s) in Company
6th Sep 20177:00 amRNSHolding(s) in Company
4th Sep 201712:07 pmRNSHolding(s) in Company
1st Sep 20173:44 pmRNSHolding(s) in Company
1st Sep 20173:28 pmRNSHolding(s) in Company
30th Aug 20175:18 pmRNSHolding(s) in Company
30th Aug 20174:09 pmRNSDirector/PDMR Shareholding
24th Aug 20173:55 pmRNSTR-1: Notification of Major Interest in Shares
22nd Aug 201712:04 pmRNSHolding(s) in Company
18th Aug 201710:10 amRNSHolding(s) in Company
17th Aug 20174:06 pmPRNForm 8 (OPD) Quantum Pharma Plc
17th Aug 201711:23 amRNSHolding(s) in Company
17th Aug 20177:00 amRNSHolding(s) in Company
15th Aug 20177:00 amRNSHolding(s) in Company
9th Aug 201712:40 pmRNSHolding(s) in Company
3rd Aug 20178:42 amRNSTR1 - Notification of Major Holdings
28th Jul 20178:25 amRNSHolding(s) in Company
27th Jul 20175:36 pmRNSDirector dealings
24th Jul 20172:05 pmRNSHolding(s) in Company
20th Jul 20174:55 pmRNSHolding(s) in Company
19th Jul 20175:16 pmRNSHolding(s) in Company
12th Jul 201711:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.